You are here

  • Home
  • Archive
  • Volume 17, Issue 5
  • Of people admitted within 2 h of mild/improving stroke, 31% do not receive rtPA, although many of these people have poor outcomes

Article Text

Article menu
Download PDFPDF
Prognosis
Cohort study
Of people admitted within 2 h of mild/improving stroke, 31% do not receive rtPA, although many of these people have poor outcomes
  1. Joshua Z Willey
  1. Division of Stroke, Department of Neurology, Columbia University, New York, USA
  1. Correspondence to Joshua Z Willey
    Division of Stroke, Department of Neurology, Columbia University, 710 West 168th street, New York, NY 10032, USA; Jzw2{at}columbia.edu

https://doi.org/10.1136/ebmed-2011-100454

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke 2011;42:3110–15.OpenUrlAbstract/FREE Full Text

    Context

    Few patients with acute ischaemic stroke receive intravenous recombinant tissue plasminogen activator (rtPA), with the main exclusion criterion being hospital arrival after 4½ h.1 The second most common exclusion criterion from rtPA treatment, which is present in approximately 1/3 of all patients, is a mild or rapidly improving syndrome, termed ‘too good to treat’.2 Uncertainty remains as to whether these patients …

    View Full Text

    Footnotes

    • Competing interests None.